001540 — Ahn-Gook Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Ahn-Gook Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	155,852	143,364	163,534	205,389	233,676
Cost of Revenue
Gross Profit	77,994	84,893	101,018	126,279	140,571
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	154,989	143,425	164,618	196,221	228,679
Operating Profit	862	-61.2	-1,084	9,167	4,997
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,176	778	3,805	7,375	4,267
Provision for Income Taxes
Net Income After Taxes	2,142	-1,388	3,744	6,879	998
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,536	-1,315	3,939	6,875	1,290
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,536	-1,315	3,939	6,875	1,290
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	353	-111	332	644	116
Dividends per Share